Latest News

Friday, May 26, 2017 | Health Care, Johnson & Johnson Vision Care

Johnson & Johnson Reps, AOA Execs Meet With FTC to Discuss Contact Lens Rule

Representatives of Johnson & Johnson Vision, the Coalition for Patient Vision Safety and the American Optometric Association (AOA) met earlier this week with Federal Trade Commission (FTC) acting …

Read the full story

Friday, May 26, 2017 | Medical Studies

Diabetic Macular Edema Rates Increase After Cataract Surgery

The rates of treatment-requiring diabetic macular edema (DME) increase sharply in the year after cataract surgery, according to new findings from the U.K. Cataract surgery leads to increased levels of…

Read the full story

Friday, May 26, 2017 | Earnings & Financials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Announces Public Offering of Common Stock

Aerie Pharmaceuticals announced that it has commenced a registered underwritten public offering of $50 million of shares of its common stock. Cantor Fitzgerald & Co. is acting as the sole bookr…

Read the full story

Thursday, May 25, 2017 | Medical Studies

Warby Parker Wants to Check Your Eyeglass Prescription with an App, But Some are Calling the Approach 'Dangerous'

Warby Parker, the $1 billion+ eyeglasses retailer, just launched an app that could make it easier to check your eyeglass prescription. The app, called Prescription Check, is meant to help people check…

Read the full story

Thursday, May 25, 2017 | Conferences

Housing, Meeting Registration Are Now Open for 2018 ASCRS Annual Meeting in Washington, D.C.

The ASCRS•ASOA Symposium & Congress is headed to Washington, D.C. during cherry blossom season in 2018 -- and housing and registration are now open. Are you planning to attend? If so, you&r…

Read the full story

Thursday, May 25, 2017 | Medical Studies

Putative Protective Role of Lutein and Zeaxanthin in Diabetic Retinopathy

DR remains one of the most debilitating complications of diabetes with a very heavy socioeconomic burden. Despite optimal control of blood glucose and advances in the treatment of diabetic eye disease…

Read the full story

Wednesday, May 24, 2017 | Clinical Trials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for Roclatan

Aerie Pharmaceuticals reported the successful primary efficacy results of the company’s 90-day, phase 3 Mercury 2 registration trial for its fixed-dose combination product candidate, Roclatan. T…

Read the full story

Wednesday, May 24, 2017 | Conferences, ThromboGenics

ThromboGenics to present THR-317 Preclinical Research Findings at the European Association for the Study of Diabetes, Eye Complications Study Group Meeting

ThromboGenics announced that it will give a presentation at the European Association for the Study of Diabetes, Eye Complications Study Group (EASDec) Meeting, which is being held in Budapest, Hungary…

Read the full story

Wednesday, May 24, 2017 | Retina

ProtoKinetix Completes First Year of Trials on Retinal Replacement Therapy Using AAGP

ProtoKinetix announced that it has completed the first year of retinal replacement therapy trials on animals and the results are encouraging enough to proceed to a second phase of testing. The stud…

Read the full story

Tuesday, May 23, 2017 | Acquisitions/Mergers

ClearSight Announces Sale of Parent Company, Sharklet Technologies

ClearSight LLC has announcd the acquisition of its parent company Sharklet Technologies by Peaceful Union, an equity medical device firm in Hangzhou, China. ClearSight LLC was co-founded by Drs. Kevin…

Read the full story

Tuesday, May 23, 2017 | Medical Studies, Glaukos Corporation

Study Reveals Potential Cost Efficiency of Using Two Glaukos iStent Trabecular Micro-Bypass Stents to Treat Elevated IOP

Glaukos announced that an analysis published in the Journal of Medical Economics evaluating various options for treating elevated IOP in open-angle glaucoma patients showed that two iStent Trabecular …

Read the full story

Tuesday, May 23, 2017 | Clinical Trials

Dompé Receives Positive CHMP Opinion in Europe For Oxervate for the Treatment of Adult Patients with Moderate or Severe Neurotrophic Keratitis

Dompé has announced that the Committee for Human Medicinal Products of the European Medicines Agency (EMA) has released a positive opinion, recommending the marketing authorization for Oxervate…

Read the full story

Monday, May 22, 2017 | FDA Approval/Clearance, Genentech

FDA Approves Genentech’s Actemra for Giant Cell Arteritis

Genentech announced that the FDA has approved Actemra (tocilizumab) subcutaneous injection for the treatment of giant cell arteritis (GCA), a chronic and severe autoimmune condition. Actemra is the fi…

Read the full story

Monday, May 22, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Renu Advanced Formula Multi-Purpose Solution

Bausch + Lomb announced the launch of "renu Advanced Formula" multi-purpose solution for soft and silicone hydrogel contact lenses. The formula combines three disinfectants and two surfactan…

Read the full story

Monday, May 22, 2017 | Earnings & Financials, Eyegate Pharmaceuticals

EyeGate Receives Milestone Payment from Valeant for EGP-437 for Postoperative Ocular Inflammation and Pain

EyeGate Pharmaceuticals announced that it has received its first development milestone from a subsidiary of Valeant under the company's license agreement with Valeant, pursuant to which EyeGate …

Read the full story
Load More